Literature DB >> 9464506

Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas.

F M Robertson1, M L Parrett, F S Joarder, M Ross, H M Abou-Issa, G Alshafie, R E Harris.   

Abstract

A single dose of 75 mg/kg 7,12 dimethylbenz[a]anthracene was administered to 50-day-old virgin female Sprague-Dawley rats and 100 days later, animals were randomized and provided with Teklad rodent chow mixed with a dose of 25 mg/rat/day ibuprofen for 35 days. Ibuprofen treatment reduced tumor volume (P < 0.05) and significantly inhibited gene expression of both cyclooxygenase- and cyclooxygenase-2 (P < 0.02). These results indicate that ibuprofen induced significant regression of established mammary carcinomas which was associated with inhibition of expression of isoforms of the gene responsible for prostaglandin production.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9464506     DOI: 10.1016/s0304-3835(97)00387-x

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  18 in total

Review 1.  Cyclooxygenase-2 and thromboxane synthase in non-endocrine and endocrine tumors: a review.

Authors:  Onder Onguru; Mary B Casey; Sabine Kajita; Nobuki Nakamura; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

2.  Chemopreventive effect of celecoxib and expression of cyclooxygenase-1 and cyclooxygenase-2 on chemically-induced rat mammary tumours.

Authors:  Tae Jung Jang; Ho Guen Jung; Ki Hoon Jung; Min Ku O
Journal:  Int J Exp Pathol       Date:  2002-08       Impact factor: 1.925

3.  NSAIDs and breast cancer recurrence in a prospective cohort study.

Authors:  Marilyn L Kwan; Laurel A Habel; Martha L Slattery; Bette Caan
Journal:  Cancer Causes Control       Date:  2007-04-03       Impact factor: 2.506

4.  Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database.

Authors:  M J Langman; K K Cheng; E A Gilman; R J Lancashire
Journal:  BMJ       Date:  2000-06-17

5.  JTE-522-induced apoptosis in human gastric adenocarcinoma [correction of adenocarcinoma] cell line AGS cells by caspase activation accompanying cytochrome C release, membrane translocation of Bax and loss of mitochondrial membrane potential.

Authors:  Hong-Liang Li; Dan-Dan Chen; Xiao-Hong Li; Hai-Wei Zhang; Jun-Hua Lü; Xian-Da Ren; Cun-Chuan Wang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

6.  Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the Nurses' Health Study II.

Authors:  A Heather Eliassen; Wendy Y Chen; Donna Spiegelman; Walter C Willett; David J Hunter; Susan E Hankinson
Journal:  Arch Intern Med       Date:  2009-01-26

7.  Combination chemoprevention of HER2/neu-induced breast cancer using a cyclooxygenase-2 inhibitor and a retinoid X receptor-selective retinoid.

Authors:  Powel H Brown; Kotha Subbaramaiah; Amoi P Salmon; Rebecca Baker; Robert A Newman; Peiying Yang; Xi Kathy Zhou; Reid P Bissonnette; Andrew J Dannenberg; Louise R Howe
Journal:  Cancer Prev Res (Phila)       Date:  2008-08

Review 8.  Cyclooxygenase-2 and the inflammogenesis of breast cancer.

Authors:  Randall E Harris; Bruce C Casto; Zachary M Harris
Journal:  World J Clin Oncol       Date:  2014-10-10

Review 9.  Novel agents for the prevention of breast cancer: targeting transcription factors and signal transduction pathways.

Authors:  Qiang Shen; Powel H Brown
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-01       Impact factor: 2.673

Review 10.  COX-2 inhibitors for the prevention of breast cancer.

Authors:  Louise R Howe; Andrew J Dannenberg
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-01       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.